Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TRDA | AMGN | VRTX | GILD | BMY |
| Company | Entrada Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 17.25 | 311.95 | 470.44 | 87.90 | 52.50 |
| High | 17.54 | 317.90 | 475.46 | 88.37 | 53.15 |
| Low | 17.08 | 310.63 | 468.47 | 87.48 | 52.29 |
| Last | 17.23 | 315.54 | 475.08 | 88.29 | 52.66 |
| Change | -0.05 | -0.46 | +4.72 | +0.21 | +0.16 |
| % Change | -0.29% | -0.15% | +1.00% | +0.24% | +0.30% |
| Volume | 58,100 | 2,223,500 | 721,900 | 5,846,800 | 9,654,100 |
| 20-Day Average Volume | 105,565 | 1,602,355 | 988,150 | 4,904,895 | 8,592,555 |
| Previous Close | 17.28 | 316.00 | 470.36 | 88.08 | 52.50 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 17.02 | 319.55 | 473.74 | 86.52 | 52.86 |
| 20-Day Raw Stochastic | 66.95% | 26.48% | 53.28% | 74.83% | 43.41% |
| 20-Day Relative Strength | 55.60% | 43.67% | 50.33% | 64.93% | 55.84% |
| Weighted Alpha | +20.97 | +14.32 | +23.53 | +18.25 | +5.79 |
| Today's Opinion | 100% Buy | 8% Buy | 40% Buy | 100% Buy | 72% Buy |
| Previous Opinion | 100% Buy | 8% Buy | 8% Buy | 100% Buy | 72% Buy |
| Last Month's Opinion | 64% Buy | 24% Buy | 8% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.53% since 10/23/24 | +0.20% since 10/23/24 | +1.07% since 10/23/24 | +1.22% since 10/23/24 | -0.75% since 10/23/24 |
| Low | 16.81 on 10/24/24 | 310.63 on 10/30/24 | 468.47 on 10/30/24 | 86.81 on 10/29/24 | 51.81 on 10/28/24 |
| High | 17.75 on 10/28/24 | 320.14 on 10/28/24 | 480.41 on 10/25/24 | 89.74 on 10/25/24 | 53.40 on 10/24/24 |
| 1-Month | |||||
| %Chg | +7.82% since 09/30/24 | -2.07% since 09/30/24 | +2.15% since 09/30/24 | +5.31% since 09/30/24 | +1.78% since 09/30/24 |
| Low | 15.19 on 10/01/24 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 82.82 on 10/01/24 | 51.31 on 10/15/24 |
| High | 18.01 on 10/16/24 | 329.17 on 10/11/24 | 499.09 on 10/17/24 | 89.74 on 10/25/24 | 54.54 on 10/02/24 |
| 3-Month | |||||
| %Chg | +1.95% since 07/30/24 | -5.32% since 07/30/24 | -5.48% since 07/30/24 | +13.12% since 07/30/24 | +7.36% since 07/30/24 |
| Low | 13.46 on 09/18/24 | 306.59 on 08/07/24 | 447.70 on 10/07/24 | 72.43 on 08/12/24 | 46.22 on 08/08/24 |
| High | 18.01 on 10/16/24 | 340.89 on 08/01/24 | 510.64 on 08/01/24 | 89.74 on 10/25/24 | 54.54 on 10/02/24 |
| 6-Month | |||||
| %Chg | +45.40% since 04/30/24 | +15.19% since 04/30/24 | +20.94% since 04/30/24 | +35.41% since 04/30/24 | +19.85% since 04/30/24 |
| Low | 11.98 on 05/01/24 | 273.38 on 05/01/24 | 392.47 on 05/01/24 | 62.07 on 05/31/24 | 39.35 on 07/05/24 |
| High | 18.17 on 07/16/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 89.74 on 10/25/24 | 54.54 on 10/02/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 640,956 | 169,548,800 | 122,619,088 | 109,920,336 | 106,762,624 |
| Shares Outstanding, K | 37,200 | 537,329 | 258,102 | 1,244,992 | 2,027,395 |
| Annual Sales | 129,010,000 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -6,680,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 94,690,000 | 8,388,000,000 | 2,645,600,000 | 6,954,000,000 | 12,201,000,000 |
| Last Quarter Net Income | 55,030,000 | 746,000,000 | -3,593,600,000 | 1,614,000,000 | 1,680,000,000 |
| 60-Month Beta | -0.25 | 0.61 | 0.40 | 0.18 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.55 on 08/13/24 | 5.58 on 10/30/24 | -12.83 on 08/01/24 | 2.01 on 08/08/24 | 2.07 on 07/26/24 |
| Latest Earnings Date | 11/05/24 | 10/30/24 | 11/04/24 | 11/06/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.770 on 09/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 09/13/24 | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 5.84 | 16.99 | 0.00 | 18.74 | 38.32 |